MAPK14 and cancer: In particular, the TGF-β/p38 mitogen-activated protein kinase (MAPK) signaling pathway is a well-investigated inducer of EMT in a variety of cancers, including lung cancer, renal cancer, breast cancer, and liver cancer [26-29].